Operating Lease, Right-of-Use Asset of TELA Bio, Inc. from 31 Mar 2022 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: TELA Bio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2022 to 30 Sep 2025.
TELA Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,560,000, a 13% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

TELA Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$1,560,000	-$236,000	-13%	30 Sep 2025	10-Q	14 Nov 2025	2025	Q3
Q2 2025	$1,616,000	-$235,000	-13%	30 Jun 2025	10-Q	11 Aug 2025	2025	Q2
Q1 2025	$1,678,000	-$226,000	-12%	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	$1,738,000	-$216,000	-11%	31 Dec 2024	10-Q	14 Nov 2025	2025	Q3
Q3 2024	$1,796,000	+$694,000	+63%	30 Sep 2024	10-Q	08 Nov 2024	2024	Q3
Q2 2024	$1,851,000	+$706,000	+62%	30 Jun 2024	10-Q	13 Aug 2024	2024	Q2
Q1 2024	$1,904,000	+$717,000	+60%	31 Mar 2024	10-Q	10 May 2024	2024	Q1
Q4 2023	$1,954,000	+$727,000	+59%	31 Dec 2023	10-K	21 Mar 2025	2024	FY
Q3 2023	$1,102,000	-$164,000	-13%	30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q2 2023	$1,145,000	-$159,000	-12%	30 Jun 2023	10-Q	10 Aug 2023	2023	Q2
Q1 2023	$1,187,000	-$152,000	-11%	31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$1,227,000			31 Dec 2022	10-K	22 Mar 2024	2023	FY
Q3 2022	$1,266,000			30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$1,304,000			30 Jun 2022	10-Q	11 Aug 2022	2022	Q2
Q1 2022	$1,339,000			31 Mar 2022	10-Q	11 May 2022	2022	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.